Oral Bisphosphonates May Lower Colorectal Cancer Risk

Use of bisphosphonates tied to reduced cancer risk in postmenopausal women

THURSDAY, Feb. 17 (HealthDay News) -- Use of oral bisphosphonates for more than one year in postmenopausal women is associated with a 59 percent decrease in the relative risk of colorectal cancer, according to a study published online Feb. 14 in the Journal of Clinical Oncology.

Gad Rennert, M.D., Ph.D., from the Carmel Medical Center in Haifa, Israel, and colleagues used computerized pharmacy records to compare the long-term use of bisphosphonates in reducing the risk of colorectal cancer in postmenopausal women. The use of bisphosphonates prior to diagnosis in 933 postmenopausal women with colorectal cancer and 933 matched controls was investigated in a population-based case-control study.

The investigators found that the use of bisphosphonates for more than one year before diagnosis was associated with a significant reduction in the relative risk of colorectal cancer. This association persisted even after adjustment for confounding factors, including dietary factors, weight, exercise, family history, and treatment with medications such as low-dose aspirin, statins, vitamin D, or postmenopausal hormones. Concomitant treatment with statins did not result in a further risk reduction.

"These data provide evidence that oral bisphosphonates may be effective for prevention of colorectal cancer in postmenopausal women. The study demonstrated a 59 percent reduction in risk after adjustment for many known risk factors for colorectal cancer," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events